Advice
in the absence of a submission from the holder of the marketing authorisation:
fostemsavir (Rukobia®) is not recommended for use within NHSScotland.
Indication under review: In combination with other antiretrovirals for the treatment of adults with multidrug resistant HIV-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice621KB (PDF)
Medicine details
- Medicine name:
- fostemsavir (Rukobia)
- SMC ID:
- SMC2389
- Indication:
In combination with other antiretrovirals for the treatment of adults with multidrug resistant HIV-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.
- Pharmaceutical company
- ViiV Healthcare
- BNF chapter
- Infections
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 12 July 2021